A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PD
Conditions
- Parkinson's Disease, Idiopathic
Interventions
- DRUG: buntanetap/posiphen
- DRUG: Placebo
Sponsor
Annovis Bio Inc.
Collaborators